Oncology - European Medical Journal

Continue

Oncology

Filter
15 Mins
31 Mar 2025

Endometrial Cancer Research in 2024

Endometrial cancer is one of the most common gynaecological cancers in high-income countries and, for many years, has been associated…
31 Oct 2024

Tackling Infectious Diseases

This interactive article summarises key discussions from GSK sponsored symposia that took place during the ESCMID Global Congress 2024, held from 27–30th April 2024 in Barcelona, Spain.
10 Mins
29 Oct 2024

ER+/HER2- Metastatic Breast Cancer – Treatment after ET + CDK4/6i

Over 70% of breast cancers are ER+/HER2-, for which the backbone of treatment is ET.1-3 Advanced breast cancer (aBC) can be considered to…
8 Mins
29 Oct 2024

Patient-Centred Therapies for mNSCLC

The metastatic non-small cell lung cancer (mNSCLC) treatment landscape has vastly expanded over the past two decades as a result of…
5 Mins
29 Oct 2024

Synergy of Tumour and Liquid Biopsy

The symposium took place during the 2024 European Society for Medical Oncology (ESMO) Congress in Barcelona, Spain, with the goal of…
9 Mins
29 Oct 2024

Therapeutic Advances in Gastrointestinal Cancers: Immuno-oncology and Beyond

At the European Society for Medical Oncology (ESMO) Congress 2024 in Barcelona, Spain, the latest advancements in immunotherapy for…
8 Mins
29 Oct 2024

Platinum Resistance in Ovarian Cancer

Approximately 80% of females with ovarian cancer are diagnosed with advanced disease (International Federation of Gynecology and…
5 Mins
29 Oct 2024

From Podium into Practice: Working Together to Revolutionise Cancer Care in the Real World

Cancer is on course to be the leading cause of death in the EU by 2035. Europe’s population is ageing rapidly, and obesity rates continue…
We’ve noticed you’re accessing
from North/South America.